Work

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206

Year: 2007

Type: article

Study design: Clinical Trial

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428190701411458

Authors: Kristie A. Blum, Jeffrey L. Johnson, Donna Niedzwiecki, George P. Canellos, Bruce D. Cheson, Nancy L. Bartlett

Institutions: The Ohio State University, Duke Medical Center, Dana-Farber Cancer Institute, Georgetown University, Georgetown University Medical Center, Washington University in St. Louis

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G20154349, G2647518335, Cancer and Leukemia Group B Statistical Center, G3255944410, Cancer and Leukemia Group B, G474277795, Targeting Transcriptional Repression in CLL, Cancer and Leukemia Group B - The Ohio State University

OpenAlex ID: W2038994136

FWCI: 5.993

Cites: 35

Cited by: 67

Related to: 10